Marc Shay
Psychiatry · Amesbury, MANPI 1578520110
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $1,250 of the $1,301 with a category attached, or 96.1%. Eli Lilly accounts for 96.1% of it on its own, with 1 other manufacturer making up the rest.
Across 3 payments — averaging $433.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$1K
- Biogen$51
Across 207 payments — averaging $8135.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biogen$714K
- Eli Lilly$220K
- E.r. Squibb & Sons, L.L.C.$133K
- Boehringer Ingelheim International GmbH$119K
- Janssen Research & Development, LLC$111K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$55K
- plus $331K from 12 others
What the payments were for
- Consulting fees$1,25096%
- Food & beverage$514%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$1,301 in reported general payments places this provider in the 85th percentile of 1,431 psychiatry providers in Massachusetts.
Other psychiatry in Amesbury
- Theresa CerulliNorth Andover$724K
- Andrew AldridgeMedford$407K
- Amjad BahnassiWorcester$352K
- Ximena Sanchez-SamperBoston$258K
- Robert AlexanderBelmont$170K
- George PapakostasBoston$170K
- Xiangyang LiMilford$166K
- Ernesto ZilberbergNorth Andover$141K
- Maurizio FavaBoston$120K
- Craig SurmanCambridge$111K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.